Background and Purpose: Anticonvulsants targeting K + channels have not been clinically available, although neuronal hyperexcitability in seizures could be suppressed by activation of K + channels. Voltage-gated A-type K + channel (A-channel) inhibitors may be prescribed for diseases of neuromuscular junction but could cause seizures.Consistently, genetic loss of function of A-channels may also cause seizures. It is unclear why inhibition of A-channels, compared with other types of K + channels, is particularly prone to seizure induction. This hinders the development of relevant therapeutic interventions.Experimental Approach: Mechanisms underlying epileptogenesis with A-channel inhibition and antiepileptic actions of A-channel activation were investigated with electrophysiological, pharmacological, optogenetic, and behavioral approaches.